Size and Decay of HIV-1 Reservoirs in Tissues and Cerebrospinal Fluid in Participants on Long-Term Antiretroviral Therapy

Size and Decay of HIV-1 Reservoirs in Tissues and Cerebrospinal Fluid in Participants on Long-Term Antiretroviral Therapy
Enrolling By Invitation
18-99 years
All
Phase N/A
90 participants needed
1 Location

Brief description of study

The purpose of this study is to look at where human immunodeficiency virus (HIV) might be “hiding” when standard lab tests show that HIV levels in the blood are very low.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: HIV-1
  • Age: Between 18 Years - 99 Years
  • Gender: All

Male or Female Aged 18 years or older HIV

Updated on 01 Aug 2024. Study ID: 844631
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research